12/4/25 16:11 | 12/3/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Te Boekhorst Paul Francis Olivier | ME | DO | P,CEO | 2 | P.m | 80 | 5.07 | 0 | 16 | | 10 | D | | | | | | | | | | | | | | |
12/2/25 11:45 | 12/1/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | Former C | 2 | M.d | 173 | 6.09 | 0 | 28 | 46 | 90 | D | | | | | | | | | | | | | | |
12/1/25 16:33 | 11/26/25 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilkins Joseph D Jr. | CA | D | | 1 | P | 10 | 27.95 | 0 | 0 | 3 | 12 | D | | | | | | | | | | | | | | |
11/28/25 08:12 | 11/25/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Tomsche David Scott | ME | D | | 1 | P | 16 | 4.76 | 0 | 3 | 3 | 131 | M | | | | | | | | | | | | | | |
11/25/25 16:16 | 11/25/25 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Widder Kenneth J | CA | D | | 2 | M.d | 222 | 20.14 | 0 | 11 | 42 | 37 | D | | | | | | | | | | | | | | |
11/25/25 16:16 | 11/25/25 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Widder Kenneth J | CA | D | | 2 | S.d | -222 | 20.14 | 0 | -11 | | 37 | D | | | | | | | | | | | | | | |
11/25/25 13:21 | 11/24/25 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M. | CA | O | CFO | 1 | P | 124 | 26.06 | 0 | 5 | 14 | 38 | I | | | | | | | | | | | | | | |
11/24/25 16:09 | 11/21/25 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Polan Mary Lake Ph D | CA | D | | 1 | P | 22 | 22.43 | 0 | 1 | 3 | 30 | D | | | | | | | | | | | | | | |
11/20/25 16:16 | 11/19/25 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Blaser Brian J. | CA | O | P,CEO | 1 | P | 502 | 21.34 | 0 | 24 | 134 | 41 | I | | | | | | | | | | | | | | |
11/17/25 16:17 | 11/13/25 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wright Richard M. | NJ | H | Former O | 2 | M.d | 1,876 | 19.03 | 0 | 99 | | 21 | D | | | | | | | | | | | | | | |
11/17/25 16:17 | 11/13/25 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wright Richard M. | NJ | H | Former O | 2 | S.d | -1,876 | 19.03 | 0 | -99 | | 21 | D | | | | | | | | | | | | | | |
11/17/25 13:12 | 11/17/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 3 | P.d | 73 | 0.5033 | 0 | 145 | 4 | 3,667 | D | | | | | | | | | | | | | | |
11/13/25 16:34 | 10/31/25 | IMDX | Insight Molecular Diagnostics Inc. | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | TN | O | CFO | 2 | M.d | 0 | 0.00 | 0 | 100 | 99 | 201 | D | | | | | | | | | | | | | | |
11/10/25 17:01 | 11/7/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 2 | M.d | 11,419 | 520.11 | 0 | 22 | | 21 | D | | | | | | | | | | | | | | |
11/10/25 17:01 | 11/7/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 2 | S.d | -11,419 | 520.11 | 0 | -22 | | 21 | D | | | | | | | | | | | | | | |
11/7/25 12:20 | 11/3/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Nassif Mikheal | MI | DO | CEO | 1 | P | 1 | 6.25 | 0 | 0 | 56 | 0 | I | | | | | | | | | | | | | | |
10/29/25 10:13 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | MI | D | | 3 | M.d | 35 | 5.99 | 0 | 6 | 6 | 96 | D | | | | | | | | | | | | | | |
10/29/25 10:08 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Capello Jeffrey D | MI | D | | 3 | M.d | 35 | 5.99 | 0 | 6 | 22 | 33 | D | | | | | | | | | | | | | | |
10/29/25 10:06 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | 2 | M.d | 23 | 5.89 | 0 | 4 | 26 | 19 | D | | | | | | | | | | | | | | |
10/29/25 10:03 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Gupta Aashima | MI | D | | 2 | M.d | 23 | 5.89 | 0 | 4 | 16 | 28 | D | | | | | | | | | | | | | | |
10/28/25 15:51 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rodriguez Rafael A | MI | D | | 2 | M.d | 23 | 5.89 | 0 | 4 | 23 | 21 | D | | | | | | | | | | | | | | |
10/28/25 15:48 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | 2 | M.d | 23 | 5.89 | 0 | 4 | 10 | 43 | D | | | | | | | | | | | | | | |
10/28/25 15:39 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Woteki Catherine E | MI | D | | 2 | M.d | 23 | 5.89 | 0 | 4 | 25 | 19 | D | | | | | | | | | | | | | | |
10/28/25 13:57 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | 3 | M.d | 109 | 5.79 | 0 | 19 | 49 | 57 | D | | | | | | | | | | | | | | |
10/28/25 13:36 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | Former C | 3 | M.d | 174 | 5.94 | 0 | 29 | 41 | 101 | D | | | | | | | | | | | | | | |
10/28/25 13:27 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | Former C | 3 | M.d | 444 | 5.94 | 0 | 75 | 26 | 363 | D | | | | | | | | | | | | | | |
10/28/25 13:12 | 10/27/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | MI | D | | 2 | M.d | 33 | 5.91 | 0 | 6 | 13 | 48 | D | | | | | | | | | | | | | | |
10/15/25 16:05 | 10/14/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | 1 | P.d | 49 | 0.5100 | 0 | 96 | 3 | 3,437 | D | | | | | | | | | | | | | | |
10/15/25 16:05 | 10/14/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Still Timothy I | NV | D | | 1 | P.d | 25 | 0.5100 | 0 | 48 | 3 | 1,535 | D | | | | | | | | | | | | | | |
10/3/25 17:13 | 10/1/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schultes Birgit C | MA | O | EVP,Chie | 1 | S | -1 | 17.39 | 0 | 0 | 0 | 105 | D | | | | | | | | | | | | | | |
10/3/25 17:13 | 10/1/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -33 | 17.38 | 0 | -2 | | 55 | D | | | | | | | | | | | | | | |
10/1/25 16:55 | 9/30/25 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 2 | M.d | 5,927 | 59.51 | 0 | 100 | 914 | 111 | D | | | | | | | | | | | | | | |
10/1/25 16:55 | 9/30/25 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 2 | S.d | -5,927 | 59.51 | 0 | -100 | | 111 | D | | | | | | | | | | | | | | |
9/22/25 16:31 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | 2 | M.d | 146 | 0.6703 | 0 | 218 | | 128 | D | | | | | | | | | | | | | | |
9/22/25 16:31 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | 2 | S.d | -146 | 0.6703 | 0 | -218 | | 128 | D | | | | | | | | | | | | | | |
9/22/25 16:29 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | CEO | 2 | M.d | 378 | 0.8856 | 0 | 427 | | 230 | D | | | | | | | | | | | | | | |
9/22/25 16:29 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | CEO | 2 | S.d | -378 | 0.8856 | 0 | -427 | | 230 | D | | | | | | | | | | | | | | |
9/19/25 17:26 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | | T | | 1 | P.d | 500 | 0.4500 | 0 | 1,111 | 41 | 3,830 | I | | | | | | | | | | | | | | |
9/19/25 17:26 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cohen Jeffrey K | | D | | 1 | P.d | 25 | 0.4500 | 0 | 56 | 15 | 437 | I | | | | | | | | | | | | | | |
9/19/25 16:05 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fraser John D | PA | D | | 1 | P.d | 7 | 0.4500 | 0 | 16 | 2 | 858 | D | | | | | | | | | | | | | | |